NASDAQ: SPECSpectaire Holdings Inc Stock
$0.65+0.08 (+14.04%)
Updated Apr 26, 2024
SPEC Price
$0.65
Fair Value Price
N/A
Market Cap
$9.96M
52 Week Low
$0.52
52 Week High
$15.40
P/E
0.61x
P/B
-0.37x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$8.95M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.05
Operating Cash Flow
-$7M
Beta
0.09
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
SPEC Overview
Perception Capital Corp. II is a "blank check" company formed to effect mergers, stock purchases, or similar combinations with one or more businesses. It targets tech-enabled industrial companies with proven business models. Perception Capital Corp. II was incorporated in 2021 and is headquartered in Wayzata, MN.
Zen Score
–
Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SPEC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SPEC is good value based on its earnings relative to its share price (0.61x), compared to the US market average (41.14x)
P/E vs Market Valuation
SPEC is good value based on its earnings relative to its share price (0.61x), compared to the US Pollution & Treatment Controls industry average (13.17x)
P/E vs Industry Valuation
SPEC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more SPEC due diligence checks available for Premium users.
Be the first to know about important SPEC news, forecast changes, insider trades & much more!
SPEC News
Valuation
SPEC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
0.61x
Industry
13.17x
Market
41.14x
SPEC is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
SPEC is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
SPEC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-0.37x
Industry
7.43x
SPEC's financial health
Profit margin
Revenue
$0.0
Net Income
$30.5M
Profit Margin
0%
SPEC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$1.4M
Liabilities
$28.6M
Debt to equity
-1.05
SPEC's short-term liabilities ($26.53M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SPEC's long-term liabilities ($2.10M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SPEC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SPEC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$1.9M
Investing
$484.1k
Financing
$1.6M
SPEC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
SPEC vs Pollution & Treatment Control Stocks
Spectaire Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.